Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 1 1

Status

Completed 4Active not recruiting 3Recruiting 2Unknown 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Breast 1

Conditions

Pancreatic Neoplasms 26Carcinoma, Non-Small-Cell Lung 14Breast Neoplasms 14Neoplasm Metastasis 7Triple Negative Breast Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Parkinson Disease 4, Autosomal Dominant Lewy Body 3Neoplasms 3Stomach Neoplasms 2Ovarian Neoplasms 2Metastatic Pancreatic Ductal Adenocarcinoma 2Lung Neoplasms 2Inflammatory Breast Neoplasms 2Uveal Melanoma 1Uterine Cervical Neoplasms 1Unresectable Biliary Tract Cancer 1Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thromboembolism 1TNBC 1Sarcoma 1Peritoneal Neoplasms 1Oropharyngeal Neoplasms 1Non-small Cell Lung Cancer Metastatic 1Mouth Neoplasms 1Locally Advanced or Metastatic Solid Tumours 1Locally Advanced Unresectable Pancreatic Cancer Treated With Chemoradiotherapy 1Lip Neoplasms 1Laryngeal Neoplasms 1Head and Neck Neoplasms 1

Interventions

pembrolizumab 33Cisplatin 11Paclitaxel 9lenvatinib 6Carboplatin 6belzutifan 5Saline Solution 4Pemetrexed 4Oxaliplatin 4Fluorouracil 4Leucovorin 3Etoposide 3Docetaxel 3Albumin-Bound Paclitaxel 3130-nm albumin-bound paclitaxel 3olaparib 2enfortumab vedotin 2durvalumab 2Radiotherapy 2Levoleucovorin 2Glucose 2Capecitabine 2Bevacizumab 2zanidatamab 1tislelizumab 1sacituzumab govitecan 1liposomal doxorubicin 1enzalutamide 1balstilimab 1avelumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Active not recruiting × Parkinson Disease 4, Autosomal Dominant Lewy Body × 130-nm albumin-bound paclitaxel × Clear all
NCT05017012 2026-03-27

MK-3475A-C18

Merck Sharp & Dohme LLC

Phase 1 Active not recruiting
72 enrolled

Parkinson Disease 4, Autosomal Dominant Lewy Body

NCT04895358 2026-03-11

KEYNOTE-B49

Merck Sharp & Dohme LLC

Phase 3 Active not recruiting
340 enrolled
Breast

Parkinson Disease 4, Autosomal Dominant Lewy Body, Breast Neoplasms, Neoplasm Metastasis

NCT04956692 2024-12-03

MK-3475-A86

Merck Sharp & Dohme LLC

Phase 3 Active not recruiting
531 enrolled 18 charts
Thoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡